MEMO1 and breast cancer: Our analysis of the Cancer Genome Atlas (https://www.cancer.gov/tcga) data reveals that, in addition to breast cancer (p<10–29 by Mann-Whitney U-test), MEMO1 is overexpressed in the malignancies of colon, lung, and uterine origins (p<0.0001), among others, while kidney, head, and neck squamous cell tumors and melanoma show little or no difference in median expression levels (Figure 1A and B).